$131.80
00.00%
Last update: Jul 5, 4:00 PM
15 minutes delayed
Tenet Healthcare
THCNYSE
want to know what
the Bulls & Bears Say?
Tenet Healthcare (NYSE:THC) Stock, Analyst Ratings, Price Targets, Forecasts
Tenet Healthcare Corp has a consensus price target of $109.32 based on the ratings of 100 analysis. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Deutsche Bank, and JP Morgan on July 2, 2024, June 28, 2024, and May 30, 2024, respectively. With an average price target of $135.67 between Cantor Fitzgerald, Deutsche Bank, and JP Morgan, there's an implied 5.39% upside for Tenet Healthcare Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
Deutsche Bank
JP Morgan
Baird
Barclays
1calculated from analyst ratings
Analyst Ratings for Tenet Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/02/2024 | Buy Now | -13% | Cantor Fitzgerald | Sarah James | $112 → $112 | Reiterates | Overweight → Overweight | Get Alert |
| 06/28/2024 | Buy Now | 20.41% | Deutsche Bank | Pito Chickering | $150 → $155 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 8.75% | JP Morgan | Lisa Gill | $107 → $140 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 16.52% | Deutsche Bank | Pito Chickering | $126 → $150 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 18.85% | Baird | Michael Ha | → $153 | Initiates | → Outperform | Get Alert |
| 05/02/2024 | Buy Now | 14.19% | Barclays | Andrew Mok | $113 → $147 | Maintains | Overweight | Get Alert |
| 05/01/2024 | Buy Now | -5.23% | Stephens & Co. | Scott Fidel | $95 → $122 | Maintains | Equal-Weight | Get Alert |
| 05/01/2024 | Buy Now | 5.65% | RBC Capital | Ben Hendrix | $109 → $136 | Maintains | Outperform | Get Alert |
| 05/01/2024 | Buy Now | 16.52% | UBS | A.J. Rice | $137 → $150 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | 0.99% | Mizuho | Ann Hynes | $118 → $130 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | 0.99% | Truist Securities | David Macdonald | $120 → $130 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | -2.12% | Deutsche Bank | Pito Chickering | $100 → $126 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | -19.21% | Cantor Fitzgerald | Sarah James | → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 03/28/2024 | Buy Now | -10.67% | Wells Fargo | Stephen Baxter | $105 → $115 | Maintains | Overweight | Get Alert |
| 03/27/2024 | Buy Now | -5.23% | Wolfe Research | Justin Lake | → $122 | Upgrade | Peer Perform → Outperform | Get Alert |
| 03/11/2024 | Buy Now | -14.55% | Mizuho | Ann Hynes | $100 → $110 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | -12.22% | Barclays | Andrew Mok | → $113 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | -19.21% | Cantor Fitzgerald | Sarah James | → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 02/15/2024 | Buy Now | -18.43% | Wells Fargo | Stephen Baxter | $98 → $105 | Maintains | Overweight | Get Alert |
| 02/09/2024 | Buy Now | -18.43% | Truist Securities | David Macdonald | $92 → $105 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -15.33% | RBC Capital | Ben Hendrix | $97 → $109 | Maintains | Outperform | Get Alert |
| 02/09/2024 | Buy Now | -22.32% | Mizuho | Ann Hynes | $90 → $100 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -19.21% | Cantor Fitzgerald | Sarah James | $94 → $104 | Maintains | Overweight | Get Alert |
| 11/20/2023 | Buy Now | -28.53% | Truist Securities | David Macdonald | → $92 | Reiterates | Buy → Buy | Get Alert |
| 11/17/2023 | Buy Now | -37.08% | JP Morgan | Calvin Sternick | $91 → $81 | Maintains | Overweight | Get Alert |
| 11/14/2023 | Buy Now | -33.97% | Jefferies | Brian Tanquilut | $95 → $85 | Maintains | Buy | Get Alert |
| 11/09/2023 | Buy Now | -33.97% | Goldman Sachs | Jamie Perse | $98 → $85 | Maintains | Buy | Get Alert |
| 11/02/2023 | Buy Now | -26.98% | UBS | Andrew Mok | $104 → $94 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | -30.09% | Raymond James | John Ransom | $95 → $90 | Maintains | Strong Buy | Get Alert |
| 10/31/2023 | Buy Now | -40.18% | Mizuho | Ann Hynes | $94 → $77 | Maintains | Buy | Get Alert |
| 10/31/2023 | Buy Now | -44.07% | RBC Capital | Ben Hendrix | $87 → $72 | Maintains | Outperform | Get Alert |
| 10/20/2023 | Buy Now | -44.85% | Wells Fargo | Stephen Baxter | $83 → $71 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | -26.98% | Cantor Fitzgerald | Sarah James | $76 → $94 | Maintains | Overweight | Get Alert |
| 08/14/2023 | Buy Now | -23.87% | Goldman Sachs | Jamie Perse | $89 → $98 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | -23.87% | Credit Suisse | A.J. Rice | $92 → $98 | Maintains | Outperform | Get Alert |
| 08/02/2023 | Buy Now | -26.2% | Raymond James | John Ransom | $85 → $95 | Maintains | Strong Buy | Get Alert |
| 08/01/2023 | Buy Now | -19.21% | UBS | Andrew Mok | $95 → $104 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | -32.42% | RBC Capital | Ben Hendrix | $84 → $87 | Maintains | Outperform | Get Alert |
| 08/01/2023 | Buy Now | -30.86% | Stephens & Co. | Scott Fidel | $87 → $89 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | Buy Now | -30.09% | Citigroup | Jason Cassorla | $83 → $90 | Maintains | Buy | Get Alert |
| 07/11/2023 | Buy Now | -26.98% | Mizuho | Ann Hynes | $81 → $94 | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | -28.53% | Truist Securities | Ryan MacDonald | $84 → $92 | Maintains | Buy | Get Alert |
| 06/14/2023 | Buy Now | -26.2% | Jefferies | Brian Tanquilut | → $95 | Reiterates | → Buy | Get Alert |
| 05/16/2023 | Buy Now | -37.08% | Mizuho | Ann Hynes | $78 → $81 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | -37.08% | Deutsche Bank | Pito Chickering | $65 → $81 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | -34.75% | Truist Securities | Ryan MacDonald | $74 → $84 | Maintains | Buy | Get Alert |
| 04/26/2023 | Buy Now | -34.75% | RBC Capital | Ben Hendrix | $73 → $84 | Maintains | Outperformer | Get Alert |
| 04/26/2023 | Buy Now | -33.97% | Raymond James | John Ransom | $72 → $85 | Maintains | Strong Buy | Get Alert |
| 04/26/2023 | Buy Now | -40.18% | Stephens & Co. | Scott Fidel | $64 → $77 | Maintains | Equal-Weight | Get Alert |
| 04/26/2023 | Buy Now | -18.43% | Barclays | Steve Valiquette | $70 → $105 | Maintains | Overweight | Get Alert |
| 04/21/2023 | Buy Now | -43.29% | Cantor Fitzgerald | Sarah James | → $73 | Initiates | → Overweight | Get Alert |
| 04/19/2023 | Buy Now | -44.07% | JP Morgan | Calvin Sternick | → $72 | Initiates | → Overweight | Get Alert |
| 02/22/2023 | Buy Now | -50.28% | Stephens & Co. | Scott Fidel | $60 → $64 | Maintains | Equal-Weight | Get Alert |
| 02/17/2023 | Buy Now | -47.18% | Wells Fargo | Stephen Baxter | $59 → $68 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | -39.41% | Mizuho | Ann Hynes | $60 → $78 | Maintains | Buy | Get Alert |
| 02/14/2023 | Buy Now | -39.41% | UBS | Andrew Mok | $47 → $78 | Maintains | Buy | Get Alert |
| 02/14/2023 | Buy Now | -45.62% | Barclays | Steve Valiquette | $67 → $70 | Maintains | Overweight | Get Alert |
| 02/10/2023 | Buy Now | -49.51% | Deutsche Bank | Pito Chickering | $48 → $65 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | -48.73% | Truist Securities | David Macdonald | $60 → $66 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | -43.29% | RBC Capital | Ben Hendrix | $69 → $73 | Maintains | Outperform | Get Alert |
| 02/10/2023 | Buy Now | -53.39% | Stephens & Co. | Scott Fidel | $57 → $60 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | -53.39% | Mizuho | Ann Hynes | → $60 | Reiterates | → Buy | Get Alert |
| 01/03/2023 | Buy Now | -54.17% | Wells Fargo | Stephen Baxter | $48 → $59 | Maintains | Overweight | Get Alert |
| 11/02/2022 | Buy Now | -53.39% | Mizuho | Ann Hynes | $80 → $60 | Maintains | Buy | Get Alert |
| 11/01/2022 | Buy Now | -37.85% | Goldman Sachs | Jamie Perse | $93 → $80 | Maintains | Buy | Get Alert |
| 10/27/2022 | Buy Now | -37.85% | Raymond James | John Ransom | $135 → $80 | Maintains | Strong Buy | Get Alert |
| 10/25/2022 | Buy Now | -40.96% | Citigroup | Jason Cassorla | $99 → $76 | Maintains | Buy | Get Alert |
| 10/25/2022 | Buy Now | -57.27% | SVB Leerink | Whit Mayo | $89 → $55 | Maintains | Outperform | Get Alert |
| 10/24/2022 | Buy Now | -65.04% | Stephens & Co. | Scott Fidel | $65 → $45 | Maintains | Equal-Weight | Get Alert |
| 10/24/2022 | Buy Now | -62.71% | Deutsche Bank | Pito Chickering | $90 → $48 | Maintains | Buy | Get Alert |
| 10/24/2022 | Buy Now | -62.71% | Wells Fargo | Stephen Baxter | $82 → $48 | Maintains | Overweight | Get Alert |
| 10/24/2022 | Buy Now | -47.95% | Barclays | Sarah James | $104 → $67 | Maintains | Overweight | Get Alert |
| 08/24/2022 | Buy Now | -27.76% | SVB Leerink | Whit Mayo | $88 → $93 | Maintains | Outperform | Get Alert |
| 08/02/2022 | Buy Now | -37.85% | Mizuho | Ann Hynes | $63 → $80 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | -29.31% | UBS | Andrew Mok | $113 → $91 | Maintains | Buy | Get Alert |
| 07/26/2022 | Buy Now | -23.09% | Citigroup | Jason Cassorla | $110 → $99 | Maintains | Buy | Get Alert |
| 07/26/2022 | Buy Now | 4.87% | Raymond James | John Ransom | $110 → $135 | Maintains | Strong Buy | Get Alert |
| 07/25/2022 | Buy Now | -23.09% | RBC Capital | Frank Morgan | $104 → $99 | Maintains | Outperform | Get Alert |
| 07/25/2022 | Buy Now | -37.85% | Truist Securities | David Macdonald | $75 → $80 | Maintains | Buy | Get Alert |
| 07/25/2022 | Buy Now | -23.09% | Citigroup | Jason Cassorla | $110 → $99 | Maintains | Buy | Get Alert |
| 07/25/2022 | Buy Now | -31.64% | SVB Leerink | Whit Mayo | $68 → $88 | Maintains | Outperform | Get Alert |
| 07/15/2022 | Buy Now | -47.18% | SVB Leerink | Whit Mayo | $110 → $68 | Maintains | Outperform | Get Alert |
| 07/12/2022 | Buy Now | -27.76% | Goldman Sachs | Jamie Perse | $108 → $93 | Maintains | Buy | Get Alert |
| 07/11/2022 | Buy Now | -14.55% | Raymond James | John Ransom | $120 → $110 | Maintains | Strong Buy | Get Alert |
| 07/07/2022 | Buy Now | -30.09% | Deutsche Bank | Pito Chickering | $110 → $90 | Maintains | Buy | Get Alert |
| 07/01/2022 | Buy Now | -51.06% | Mizuho | Ann Hynes | $103 → $63 | Maintains | Buy | Get Alert |
| 06/17/2022 | Buy Now | -37.85% | Loop Capital | Joseph France | → $80 | Initiates | → Buy | Get Alert |
| 04/25/2022 | Buy Now | -30.09% | Wells Fargo | Stephen Baxter | $100 → $90 | Maintains | Overweight | Get Alert |
| 04/22/2022 | Buy Now | -14.55% | Deutsche Bank | Pito Chickering | $100 → $110 | Maintains | Buy | Get Alert |
| 04/22/2022 | Buy Now | -14.55% | Citigroup | Jason Cassorla | $96 → $110 | Maintains | Buy | Get Alert |
| 04/22/2022 | Buy Now | -19.21% | Barclays | Sarah James | $99 → $104 | Maintains | Overweight | Get Alert |
| 04/22/2022 | Buy Now | -14.55% | SVB Leerink | Whit Mayo | $100 → $110 | Maintains | Outperform | Get Alert |
| 04/22/2022 | Buy Now | -19.21% | RBC Capital | Ben Hendrix | $89 → $104 | Maintains | Outperform | Get Alert |
| 03/29/2022 | Buy Now | -22.32% | Wells Fargo | Stephen Baxter | → $100 | Initiates | → Overweight | Get Alert |
| 03/07/2022 | Buy Now | -2.9% | Jefferies | Brian Tanquilut | $120 → $125 | Maintains | Buy | Get Alert |
| 03/03/2022 | Buy Now | -19.99% | Mizuho | Ann Hynes | $90 → $103 | Maintains | Buy | Get Alert |
| 03/01/2022 | Buy Now | — | Goldman Sachs | Jamie Perse | — | Reinstates | → Buy | Get Alert |
| 02/10/2022 | Buy Now | -13.77% | UBS | Andrew Mok | $83 → $111 | Upgrade | Neutral → Buy | Get Alert |
| 02/09/2022 | Buy Now | -13.77% | Credit Suisse | A.J. Rice | $109 → $111 | Maintains | Outperform | Get Alert |
| 02/09/2022 | Buy Now | -22.32% | SVB Leerink | Whit Mayo | $88 → $100 | Upgrade | Market Perform → Outperform | Get Alert |
FAQ
What is the target price for Tenet Healthcare (THC) stock?
The latest price target for Tenet Healthcare (NYSE:THC) was reported by Cantor Fitzgerald on July 2, 2024. The analyst firm set a price target for $112.00 expecting THC to fall to within 12 months (a possible -15.02% downside). 41 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenet Healthcare (THC)?
The latest analyst rating for Tenet Healthcare (NYSE:THC) was provided by Cantor Fitzgerald, and Tenet Healthcare reiterated their overweight rating.
When was the last upgrade for Tenet Healthcare (THC)?
The last upgrade for Tenet Healthcare Corp happened on March 27, 2024 when Wolfe Research raised their price target to $122. Wolfe Research previously had a peer perform for Tenet Healthcare Corp.
When was the last downgrade for Tenet Healthcare (THC)?
There is no last downgrade for Tenet Healthcare.
When is the next analyst rating going to be posted or updated for Tenet Healthcare (THC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenet Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenet Healthcare was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.
Is the Analyst Rating Tenet Healthcare (THC) correct?
While ratings are subjective and will change, the latest Tenet Healthcare (THC) rating was a reiterated with a price target of $112.00 to $112.00. The current price Tenet Healthcare (THC) is trading at is $131.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.